CSIMarket


Scynexis inc   (SCYX)
Other Ticker:  
 
 

SCYX's Net Cash Flow Growth by Quarter and Year

Scynexis Inc 's Net Cash Flow results by quarter and year




SCYX Net Cash Flow (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 63.55 30.43 -
III Quarter September -12.39 -4.53 - -
II Quarter June 20.43 13.77 - -
I Quarter March -1.03 -21.67 - -
FY   7.01 51.12 30.43 -



SCYX Net Cash Flow third quarter 2021 Y/Y Growth Comment
Scynexis inc in the third quarter recorded net cash outflow of $ -12.39 millions.

Looking into third quarter results within Major Pharmaceutical Preparations industry 78 other companies have achieved higher Net Cash Flow growth. While Scynexis Inc ' s Net Cash Flow no change of % ranks overall at the positon no. 910 in the third quarter.




SCYX Net Cash Flow ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - 108.84 % - -
III Quarter September - - - -
II Quarter June 48.37 % - - -
I Quarter March - - - -
FY   - 67.99 % - -

Financial Statements
Scynexis Inc 's third quarter 2021 Net Cash Flow $ -12.39 millions SCYX's Income Statement
Scynexis Inc 's third quarter 2020 Net Cash Flow $ -4.53 millions Quarterly SCYX's Income Statement
New: More SCYX's historic Net Cash Flow Growth >>


SCYX Net Cash Flow (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - 67.99 % - -




Net Cash Flow third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #79
Healthcare Sector #194
Overall #910

Net Cash Flow Y/Y Growth Statistics
High Average Low
184.01 % 28.15 % -29.48 %
(Dec 31 2020)   (March 31, 2016)
Net Cash Flow third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #79
Healthcare Sector #194
Overall #910
Net Cash Flow Y/Y Growth Statistics
High Average Low
184.01 % 28.15 % -29.48 %
(Dec 31 2020)   (March 31, 2016)

Net Cash Flow by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Scynexis Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SCYX's III. Quarter Q/Q Net Cash Flow Comment
III. Quarter 2021 accomplishment of -12.39 millions by Scynexis inc appear even worse if you take a look at net cash outflow 20.43 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Scynexis inc achieved highest sequential Net Cash Flow growth. While Scynexis Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SCYX's III. Quarter Q/Q Net Cash Flow Comment
Recent accomplishment of -12.39 millions by Scynexis inc appear even worse considering the net cash outflow 20.43 millions a quarter before.

Within Major Pharmaceutical Preparations industry Scynexis inc achieved highest sequential Net Cash Flow growth. While Scynexis Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Scynexis Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
Cumulative Net Cash Flow 12 Months Ending $ 70.56 $ 78.42 $ 71.76 $ 51.12 $ 18.00
Y / Y Net Cash Flow Growth (TTM) 292 % - - - -
Year on Year Net Cash Flow Growth Overall Ranking # 348 # 0 # 0 # 0 # 0
Seqeuential Net Cash Flow Change (TTM) -10.03 % 9.29 % 40.37 % 184.01 % -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 910 # 718 # 826 # 331 # 0




Cumulative Net Cash Flow growth Comment
With 292% annual Net Cash Flow growth, Scynexis Inc would report a record annual Net Cash Flow surge if the fiscal year would end on Sep 30 2021.

In the Healthcare sector 82 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 0 to 348.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
184.01 %
28.15 %
-29.48 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 79
Healthcare Sector # 83
Overall # 348

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
292 %
58.97 %
-62.89 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 79
Sector # 194
S&P 500 # 910
Cumulative Net Cash Flow growth Comment
With 292% annual Net Cash Flow growth, Scynexis Inc would report a record annual Net Cash Flow surge if the fiscal year would end on Sep 30 2021.

In the Healthcare sector 82 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 0 to 348.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
184.01 %
28.15 %
-29.48 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 79
Healthcare Sector # 83
Overall # 348

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
292 %
58.97 %
-62.89 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 79
Sector # 194
S&P 500 # 910




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
SCYX's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for SCYX's Competitors
Net Cash Flow Growth for Scynexis Inc 's Suppliers
Net Cash Flow Growth for SCYX's Customers

You may also want to know
SCYX's Annual Growth Rates SCYX's Profitability Ratios SCYX's Asset Turnover Ratio SCYX's Dividend Growth
SCYX's Roe SCYX's Valuation Ratios SCYX's Financial Strength Ratios SCYX's Dividend Payout Ratio
SCYX's Roa SCYX's Inventory Turnover Ratio SCYX's Growth Rates SCYX's Dividend Comparisons



Companies with similar Net Cash Flow surge for the quarter ending Sep 30 2021 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Sep 30 2021
Acasti Pharma Inc 282.49%$ 282.494 millions
Allena Pharmaceuticals Inc 273.74%$ 273.744 millions
Myovant Sciences Ltd 238.87%$ 238.873 millions
Biohaven Pharmaceutical Holding Company Ltd 238.10%$ 238.103 millions
Arvinas Inc 207.05%$ 207.049 millions
Iteos Therapeutics Inc 193.84%$ 193.841 millions
Diamedica Therapeutics Inc 188.95%$ 188.951 millions
Rhythm Pharmaceuticals inc 168.48%$ 168.481 millions
Semler Scientific inc 135.75%$ 135.748 millions
Inmune Bio Inc 130.58%$ 130.582 millions
Fulgent Genetics Inc 126.12%$ 126.119 millions
Healthlynked Corp 110.69%$ 110.691 millions
Irhythm Technologies Inc 109.46%$ 109.459 millions
Integra Lifesciences Holdings Corp106.29%$ 106.292 millions
Twinlab Consolidated Holdings Inc 103.82%$ 103.819 millions
Radnet Inc 101.73%$ 101.726 millions
Apollo Medical Holdings Inc 101.46%$ 101.459 millions
Dexcom Inc 98.96%$ 98.957 millions
Option Care Health Inc 97.42%$ 97.421 millions
Abbvie Inc 94.13%$ 94.127 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BKYI's Profile

Stock Price

BKYI's Financials

Business Description

Fundamentals

Charts & Quotes

BKYI's News

Suppliers

BKYI's Competitors

Customers & Markets

Economic Indicators

BKYI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071